Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Arthrofibrosis].

U Bosch1

  • 1Unfallchirurgische Klinik, Medizinische Hochschule, Carl-Neuberg-Strasse 1, 30625 Hannover. bosch.ulrich@mh-hannover.de

Der Orthopade
|November 13, 2002
PubMed
Summary
This summary is machine-generated.

Arthrofibrosis, a joint condition causing motion loss, has two types: primary (unknown cause, systemic fibrosis) and secondary (complication from injury/surgery). Differentiating them guides treatment for better joint function.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Der Unfallchirurg·2016
Same author

Autologous chondrocyte implantation (ACI) for cartilage defects of the knee: A guideline by the working group "Clinical Tissue Regeneration" of the German Society of Orthopaedics and Trauma (DGOU).

The Knee·2016
Same author

[Periprosthetic knee fractures].

Der Orthopade·2015
Same author

Evaluation of trichothecene and nontrichothecene mycotoxins produced byFusarium in soybeans.

Mycotoxin research·2013
Same author

[Autologous chondrocyte implantation (ACI) for cartilage defects of the knee: a guideline by the working group "Tissue Regeneration" of the German Society of Orthopaedic Surgery and Traumatology (DGOU)].

Zeitschrift fur Orthopadie und Unfallchirurgie·2013
Same author

[Post-treatment rehabilitation after autologous chondrocyte implantation: State of the art and recommendations of the Clinical Tissue Regeneration Study Group of the German Society for Accident Surgery and the German Society for Orthopedics and Orthopedic Surgery].

Der Unfallchirurg·2012
Same journal

[Fast-track hip and knee joint arthroplasty].

Der Orthopade·2022
Same journal

[Outpatient care through cross-sector prehabilitation and rehabilitation concepts in outpatient hip and knee arthroplasty].

Der Orthopade·2022
Same journal

[Preoperative management in fast-track arthroplasty].

Der Orthopade·2022
Same journal

[Perioperative management in fast-track arthroplasty].

Der Orthopade·2022
Same journal

[Pain therapy and anaesthesiological procedures in fast-track arthroplasty].

Der Orthopade·2022
Same journal

[Discharge readiness versus discharge-Results of the PROMISE study].

Der Orthopade·2022
See all related articles

Area of Science:

  • Orthopedic Surgery
  • Biomedical Engineering
  • Rheumatology

Context:

  • Arthrofibrosis is a severe joint complication characterized by excessive fibrotic scarring and loss of motion following trauma or surgery.
  • It presents as primary arthrofibrosis with a generalized fibrotic healing response or secondary arthrofibrosis with a localized response.
  • Secondary arthrofibrosis can stem from issues like nonisometric graft positioning, notch impingement, or hardware complications.

Purpose:

  • To differentiate between primary and secondary arthrofibrosis based on etiology and clinical presentation.
  • To explore the underlying mechanisms, including extracellular matrix alterations and chronic inflammation in primary arthrofibrosis.
  • To outline distinct management strategies for both types of arthrofibrosis.

Summary:

Related Experiment Videos

  • Primary arthrofibrosis, of unknown etiology, involves systemic fibrotic responses and extracellular matrix changes, potentially linked to chronic inflammation and immune responses.
  • Secondary arthrofibrosis is a complication of joint trauma or surgery, often caused by biomechanical issues or hardware problems, leading to localized fibrosis.
  • While secondary arthrofibrosis is often treatable with arthroscopic procedures, primary arthrofibrosis may require surgical interventions like anterior compartment tissue resection and posterior capsulotomy.

Impact:

  • Distinguishing between primary and secondary arthrofibrosis is crucial for effective treatment planning and improving patient outcomes.
  • Understanding the distinct etiologies may lead to targeted therapies for primary arthrofibrosis, addressing its inflammatory and fibrotic components.
  • This distinction aids in managing patient expectations and optimizing surgical approaches for joint stiffness and functional recovery.